‘The Longevity Factor’ by Joseph Maroon, M.D.
Copyright©2009 by Maroon Enterprises (Pages 114 – 115)
Further research on resveratrol has shown that it also has promise for treating pancreatic cancer. Dr. Paul Okunieff, chief of the department of radiation oncology at the University
of Rochester Cancer Center, and his associates studied malignant human pancreatic cancer cells treated with and without resveratrol. They subjected the cells to ionizing radiation (radiation therapy). Their results were
positive in two ways. First, resveratrol appeared to act as a tumor sensitizer: that is, it made the malignant cells more sensitive to radiation therapy. It also made normal tissue less sensitive to radiation, and this lower
sensitivity would help minimize the treatment’s adverse side effects. Second, the researchers believed that resveratrol enhanced; the effects of chemotherapy. Both functions resulted in a higher kill rate of cancerous
cells, a finding they reported in the March 2000 issue of the journal Advances in Experimental Medicine and Biology.
Looking at these and other studies, we can come to several conclusions:
Xeno factors such as resveratrol, quercetin, and other compounds found in red grape skins demonstrate efficacy in preventing cancer in many animal models.
These molecules block all three mechanisms of cancer formation – initiation, promotion, and progression – through their antioxidant, anti-inflammatory, and antiangiogenic effects.
Effective treatment and prevention by xeno factors have been demonstrated in animals with cancers of the breast, skin, esophagus, colon prostate, lung, and liver.
No comments:
Post a Comment